Skip to main content
SpringerLink
Log in

Fortschritt durch Wissenschaft

DEGRO-Jahrestagung 2014

Progress through science

DEGRO Annual Congress 2014

  • Onkologiekongresse
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bujold A, Massey Ca, Kim JJ et al (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31:1631–1639

    Article  PubMed  Google Scholar 

  2. Darby S, McGale P, Correa C et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707–1716

    Article  PubMed  CAS  Google Scholar 

  3. Guckenberger M, Allgauer M, Appold S et al (2013) Safety and efficacy of stereotactic body radiotherapy for stage i non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis. J Thorac Oncol 8(8):1050–1058

    Article  PubMed  CAS  Google Scholar 

  4. Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967

    Article  PubMed  Google Scholar 

  5. Moser G (2013) Bestallungen (Approbationen) jüdischer Ärzte erlöschen am 30. September 1938“ – Vor 75 Jahren entzog der NS-Gesetzgeber Ärztinnen und Ärzten die staatliche Berufszulassung. Fortschr Röntgenstr 185(10):930–935

    Google Scholar 

  6. Moser G (2014) Radiologie in der NS-Zeit – Teil 1 bis Teil 4. Fortschr Röntgenstr 186(1):17–21, 186(2):116–119, 186(3):212–217 und 186(4):329–333

  7. Onishi H, Shirato H, Nagata Y et al (2011) Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 81(5):1352–1358

    Article  PubMed  Google Scholar 

  8. Ott OJ, Jeremias C, Gaipl US et al (2014) Radiotherapy for benign calcaneodynia: long-term results of the Erlangen Dose Optimization (EDO) trial. Strahlenther Onkol 190(7):671–675

    Article  PubMed  Google Scholar 

  9. Ott OJ, Hertel S, Gaipl US et al (2014) The erlangen dose optimization trial for low-dose radiotherapy of benign painful elbow syndrome. Long-term results. Strahlenther Onkol 190:293–297

    Article  PubMed  CAS  Google Scholar 

  10. Sedlmayer F, Sautter-Bihl ML, Budach W et al (2013) Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol 189:825–833

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  11. Verstegen NE, Oosterhuis JW, Palma DA et al (2013) Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol 24(6):1543–1548

    Article  PubMed  CAS  Google Scholar 

  12. Wenz F et al. (2014) DEGRO practical guidelines for radiotherapy of breast cancer IV: Radiotherapy following mastectomy for invasive breast cancer. Strahlenther Onkol 190(8):705–714

    Article  PubMed  Google Scholar 

Download references

Einhaltung der ethischen Richtlinien

Interessenkonflikt. F.A. Giordano gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Klinik für Strahlentherapie und Radioonkologie, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1–3, 68167, Mannheim, Deutschland

    F.A. Giordano & F. Wenz

Authors
  1. F.A. Giordano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Wenz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F.A. Giordano.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giordano, F., Wenz, F. Fortschritt durch Wissenschaft. Onkologe 20, 1014–1017 (2014). https://doi.org/10.1007/s00761-014-2780-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-014-2780-5

Search

Navigation